{"id":"W2130952724","doi":"10.1093/eurheartj/ehm575","title":"New oral anticoagulants in atrial fibrillation","year":2007,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Dabigatran; Edoxaban; Stroke (engine); Atrial fibrillation; Warfarin; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Antithrombotic; Intensive care medicine; Internal medicine; Thrombin; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001829764,0.000320162,0.001593323,0.0007738525,0.00008527622,0.0001170223,0.0001103485,0.0001241585,0.0004958357],"category_scores_gemma":[0.0002497019,0.0002462398,0.001157639,0.0004858989,0.00001711761,0.0001253689,0.00007761423,0.0006454485,0.001015596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001439165,"about_ca_system_score_gemma":0.0002885779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005851054,"about_ca_topic_score_gemma":0.000002163484,"domain_scores_codex":[0.9973548,0.0005173848,0.001052046,0.0002567113,0.0004554517,0.0003635715],"domain_scores_gemma":[0.9988689,0.0001682951,0.0003963998,0.0002281019,0.00004094712,0.0002973251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006244383,0.000001034531,0.01234754,0.0007173305,0.0001297385,0.0004255197,0.00001863535,0.000008143376,2.130179e-7,0.00002147828,0.008725994,0.9775419],"study_design_scores_gemma":[0.001199047,0.00009774489,0.01299517,0.005151903,0.0005786162,0.001299521,0.000004204596,0.000005261628,7.944175e-8,0.000007884226,0.9784455,0.0002150389],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006718194,0.9921255,0.0002713432,0.0002611872,0.001458836,0.0005732356,0.000001924978,0.00004728394,0.00519356],"genre_scores_gemma":[0.00002659843,0.9707908,0.002276913,0.00006132107,0.02146115,2.190581e-8,0.00004202356,0.0000856027,0.005255593],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9773269,"threshold_uncertainty_score":0.999999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3264621681291325,"score_gpt":0.4645953747228908,"score_spread":0.1381332065937583,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}